Literature DB >> 24563185

Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior.

Rolf T Hansen1, Marco Conti, Han-Ting Zhang.   

Abstract

RATIONALE: Phosphodiesterases (PDEs) are a super family of enzymes responsible for the halting of intracellular cyclic nucleotide signaling and may represent novel therapeutic targets for treatment of cognitive disorders. PDE4 is of considerable interest to cognitive research because it is highly expressed in the brain, particularly in the cognition-related brain regions. Recently, the functional role of PDE4B and PDE4D, two of the four PDE4 subtypes (PDE4A, B, C, and D), in behavior has begun to be identified; however, the role of PDE4A in the regulation of behavior is still unknown.
OBJECTIVES: The purpose of this study was to characterize the functional role of PDE4A in behavior.
METHODS: The role of PDE4A in behavior was evaluated through a battery of behavioral tests using PDE4A knockout (KO) mice; urine corticosterone levels were also measured.
RESULTS: PDE4A KO mice exhibited improved memory in the step-through-passive-avoidance test. They also displayed anxiogenic-like behavior in elevated-plus maze, holeboard, light-dark transition, and novelty suppressed feeding tests. Consistent with the anxiety profile, PDE4A KO mice had elevated corticosterone levels compared with wild-type controls post-stress. Interestingly, PDE4A KO mice displayed no change in object recognition, Morris water maze, forced swim, tail suspension, and duration of anesthesia induced by co-administration of xylazine and ketamine (suggesting that PDE4A KO may not be emetic).
CONCLUSIONS: These results suggest that PDE4A may be important in the regulation of emotional memory and anxiety-like behavior, but not emesis. PDE4A could possibly represent a novel therapeutic target in the future for anxiety or disorders affecting memory.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24563185     DOI: 10.1007/s00213-014-3480-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  98 in total

Review 1.  Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease.

Authors:  Nathan A Pinner; Leslie A Hamilton; Anthony Hughes
Journal:  Clin Ther       Date:  2012-01       Impact factor: 3.393

2.  Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.

Authors:  Yun-Feng Li; Yu-Fang Cheng; Ying Huang; Marco Conti; Steven P Wilson; James M O'Donnell; Han-Ting Zhang
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

3.  Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells.

Authors:  S Sheriff; F M Dautzenberg; J J Mulchahey; M Pisarska; R L Hauger; W T Chance; A Balasubramaniam; J W Kasckow
Journal:  Peptides       Date:  2001-12       Impact factor: 3.750

4.  CREB: a major mediator of neuronal neurotrophin responses.

Authors:  S Finkbeiner; S F Tavazoie; A Maloratsky; K M Jacobs; K M Harris; M E Greenberg
Journal:  Neuron       Date:  1997-11       Impact factor: 17.173

5.  Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues.

Authors:  Viktor Lakics; Eric H Karran; Frank G Boess
Journal:  Neuropharmacology       Date:  2010-05-21       Impact factor: 5.250

6.  Characterization of cAMP degradation by phosphodiesterases in the accessory olfactory system.

Authors:  James A Cherry; Vanee Pho
Journal:  Chem Senses       Date:  2002-09       Impact factor: 3.160

7.  Coordinate and divergent regulation of corticotropin-releasing factor (CRF) and CRF-binding protein expression in an immortalized amygdalar neuronal cell line.

Authors:  J J Mulchahey; A Regmi; S Sheriff; A Balasubramaniam; J W Kasckow
Journal:  Endocrinology       Date:  1999-01       Impact factor: 4.736

Review 8.  PDE5 inhibitors: considerations for preference and long-term adherence.

Authors:  W B Smith; I R McCaslin; A Gokce; S H Mandava; L Trost; W J Hellstrom
Journal:  Int J Clin Pract       Date:  2013-08       Impact factor: 2.503

9.  Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts.

Authors:  Matthew D Bruss; Wito Richter; Kathleen Horner; S-L Catherine Jin; Marco Conti
Journal:  J Biol Chem       Date:  2008-05-28       Impact factor: 5.157

10.  Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety.

Authors:  Alex B Burgin; Olafur T Magnusson; Jasbir Singh; Pam Witte; Bart L Staker; Jon M Bjornsson; Margret Thorsteinsdottir; Sigrun Hrafnsdottir; Timothy Hagen; Alex S Kiselyov; Lance J Stewart; Mark E Gurney
Journal:  Nat Biotechnol       Date:  2009-12-27       Impact factor: 54.908

View more
  18 in total

1.  Compartmentalized PDE4A5 Signaling Impairs Hippocampal Synaptic Plasticity and Long-Term Memory.

Authors:  Robbert Havekes; Alan J Park; Rosa E Tolentino; Vibeke M Bruinenberg; Jennifer C Tudor; Yool Lee; Rolf T Hansen; Leonardo A Guercio; Edward Linton; Susana R Neves-Zaph; Peter Meerlo; George S Baillie; Miles D Houslay; Ted Abel
Journal:  J Neurosci       Date:  2016-08-24       Impact factor: 6.167

2.  A Sam68-dependent alternative splicing program shapes postsynaptic protein complexes.

Authors:  Harald Witte; Dietmar Schreiner; Peter Scheiffele
Journal:  Eur J Neurosci       Date:  2019-01-29       Impact factor: 3.386

3.  Reexamining Dis/Similarity-Based Tests for Rare-Variant Association with Case-Control Samples.

Authors:  Charlotte Wang; Jung-Ying Tzeng; Pei-Zhen Wu; Martin Preisig; Chuhsing Kate Hsiao
Journal:  Genetics       Date:  2018-03-15       Impact factor: 4.562

Review 4.  Memory suppressor genes: Modulating acquisition, consolidation, and forgetting.

Authors:  Nathaniel C Noyes; Anna Phan; Ronald L Davis
Journal:  Neuron       Date:  2021-08-26       Impact factor: 18.688

5.  Studies of mice with cyclic AMP-dependent protein kinase (PKA) defects reveal the critical role of PKA's catalytic subunits in anxiety.

Authors:  George Briassoulis; Margaret F Keil; Bilal Naved; Sophie Liu; Matthew F Starost; Maria Nesterova; Nirmal Gokarn; Anna Batistatos; T John Wu; Constantine A Stratakis
Journal:  Behav Brain Res       Date:  2016-03-16       Impact factor: 3.332

6.  Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor.

Authors:  David J Titus; Nicole M Wilson; Julie E Freund; Melissa M Carballosa; Kevin E Sikah; Concepcion Furones; W Dalton Dietrich; Mark E Gurney; Coleen M Atkins
Journal:  J Neurosci       Date:  2016-07-06       Impact factor: 6.167

7.  Inhibition of cAMP-phosphodiesterase 4 (PDE4) potentiates the anesthetic effects of Isoflurane in mice.

Authors:  Ileana V Aragon; Abigail Boyd; Lina Abou Saleh; Justin Rich; Will McDonough; Anna Koloteva; Wito Richter
Journal:  Biochem Pharmacol       Date:  2021-02-18       Impact factor: 5.858

8.  The cAMP-phosphodiesterase 4 (PDE4) controls β-adrenoceptor- and CFTR-dependent saliva secretion in mice.

Authors:  Abigail Boyd; Ileana V Aragon; Lina Abou Saleh; Dylan Southers; Wito Richter
Journal:  Biochem J       Date:  2021-05-28       Impact factor: 3.766

9.  Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains.

Authors:  C Leonardo Jimenez Chavez; Camron D Bryant; Melissa A Munn-Chernoff; Karen K Szumlinski
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

Review 10.  Protein Kinase A and Anxiety-Related Behaviors: A Mini-Review.

Authors:  Margaret F Keil; George Briassoulis; Constantine A Stratakis; T John Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-29       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.